Zobrazeno 1 - 10
of 752
pro vyhledávání: '"Pneumococcal conjugate vaccines"'
Autor:
Mark A. Fletcher, Derek Daigle, Mariana Siapka, Marc Baay, Germaine Hanquet, Graciela del Carmen Morales
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundMost publications on invasive pneumococcal disease (IPD) serotype distribution are from about 20 countries (Australia, Canada, China, European Union members, Japan, New Zealand, South Korea, and USA). Here, we reviewed the literature among
Externí odkaz:
https://doaj.org/article/1ad4445014194830a721cdcefd24b962
Autor:
Mitsuyo Kawaguchiya, Noriko Urushibara, Meiji Soe Aung, Nobuhide Ohashi, Rika Takamatsu, Sho Tsutida, Masahiko Ito, Nobumichi Kobayashi
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 56, Iss 6, Pp 1288-1292 (2023)
Ten years after the introduction of the pneumococcal conjugate vaccine (PCV) in Japan, the prevalence rates of non-PCV13 and non-PCV20 serotypes among pediatric pneumococcal isolates were 94.0% and 73.7%, respectively. The predominant non-PCV13/PCV20
Externí odkaz:
https://doaj.org/article/ccd47380c5a2440e865383c796947bc1
Autor:
Anithasree Athiyaman, Putri Herliana, Atiek Anartati, Niken Widyastuti, Prima Yosephine, Gertrudis Tandy, Sherli Karolina
Publikováno v:
Infectious Diseases of Poverty, Vol 12, Iss 1, Pp 1-5 (2023)
Abstract Despite high pneumococcal disease and economic burden in Indonesia and interest to introduce pneumococcal conjugate vaccine (PCV), there were challenges in establishing a comprehensive strategy to accelerate and enable the introduction in co
Externí odkaz:
https://doaj.org/article/e5c2ce7ee5674aca8c538ac460dde580
Autor:
Matilda Emgård, Maria Andersson, Lucia Gonzales-Siles, Sia E. Msuya, Balthazar M. Nyombi, Rickard Nordén, Florida Muro, Magnus Lindh, Rune Andersson, Susann Skovbjerg
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
IntroductionPneumococcal conjugate vaccines have reduced severe disease attributed to vaccine-type pneumococci in children. However, the effect is dependent on serotype distribution in the population and disease development may be influenced by co-oc
Externí odkaz:
https://doaj.org/article/b58c7e3c716b4bf6876b7059c0e5fb14
Autor:
Weronika Puzia, Jan Gawor, Robert Gromadka, Karolina Żuchniewicz, Izabela Wróbel-Pawelczyk, Patrycja Ronkiewicz, Agnieszka Gołębiewska, Waleria Hryniewicz, Ewa Sadowy, Anna Skoczyńska
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 8, Pp 2017-2037 (2023)
Abstract Introduction The introduction of pneumococcal conjugate vaccines (PCV) into the national immunization programs (NIPs) has significantly reduced the number of pneumococcal infections. However, infections caused by isolates of non-vaccine sero
Externí odkaz:
https://doaj.org/article/a018648809314e8cb08d995025d51df0
Publikováno v:
Pneumonia, Vol 15, Iss 1, Pp 1-5 (2023)
Abstract Pneumococcal conjugate vaccines (PCVs) provide protection against vaccine-type pneumococcal disease in both children and adults. Growing evidence suggests that PCVs also reduce pneumonia and lower respiratory tract infections (LRTIs) more br
Externí odkaz:
https://doaj.org/article/d9d51b189cf2407abf3b533a48fa2cd9
Autor:
Tianyan Hu, Eric M. Sarpong, Yan Song, Nicolae Done, Qing Liu, Esteban Lemus-Wirtz, James Signorovitch, Salini Mohanty, Thomas Weiss
Publikováno v:
Pneumonia, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background Pneumonia is the most serious form of acute respiratory infection and Streptococcus pneumoniae is a leading cause of pediatric bacterial pneumonia. Pneumococcal conjugate vaccines were introduced in the United States (US) in 2000
Externí odkaz:
https://doaj.org/article/23c8e558c53241389668108740fe0d6e
Autor:
George Gourzoulidis, Myrto Barmpouni, Vasiliki Kossyvaki, Jeffrey Vietri, Charalampos Tzanetakos
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
ObjectiveHigher valency pneumococcal conjugate vaccines (PCVs) are expected to improve protection against pneumococcal disease through coverage of additional serotypes. The aim of the present study was to evaluate the cost-effectiveness of 20-valent
Externí odkaz:
https://doaj.org/article/9eeacb46524d4f8dada9aed11373b463
Autor:
Ayla Manzanal, Diego Vicente, Marta Alonso, Nekane Azkue, Maria Ercibengoa, José María Marimón
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
ObjectivesTo analyze the impact of pneumococcal conjugate vaccines (PCVs) on the incidence of invasive pneumococcal diseases (IPDs) and pneumococcal antibiotic resistance in Gipuzkoa, northern Spain for a 25 years period.MethodsAll cases of IPD confi
Externí odkaz:
https://doaj.org/article/101c5501b4ca4441abfb4c2b0be6b721
Publikováno v:
Gates Open Research, Vol 7 (2023)
The Worldwide Index of Serotype Specific Pneumococcal Antibody Responses (WISSPAR; https://wisspar.com), is a centralized, online platform housing data on immunogenicity from clinical trials of pneumococcal vaccines. The data on WISSPAR are primarily
Externí odkaz:
https://doaj.org/article/991d754c42f740aebf1bcbd10e72193c